| Unique ID issued by UMIN | UMIN000059764 |
|---|---|
| Receipt number | R000068231 |
| Scientific Title | The effect of honey intake on blood glucose responses |
| Date of disclosure of the study information | 2026/02/20 |
| Last modified on | 2025/11/11 17:04:55 |
The effect of honey intake on blood glucose responses
The effect of honey intake on blood glucose responses
The effect of honey intake on blood glucose responses
The effect of honey intake on blood glucose responses
| Japan |
Adult
| Adult |
Others
NO
To evaluate the change of blood glucose level by the test foods
Efficacy
Confirmatory
Blood glucose level
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
Intake of a test food 1- washout period - a test food 2
Dose: 250ml
Single ingestion
Intake of a test food 2- washout period - a test food 1
Dose: 250ml
Single ingestion
| 20 | years-old | <= |
| 59 | years-old | >= |
Male and Female
(1) Healthy males and females, aged 20 to 59 years at the time of providing consent
(2) Subjects with a BMI of less than 30 kg/m2
(3) Subjects who are able to provide fingertip blood sample (8 times/day for 3 observation periods)
(4) Subjects with normal blood glucose and HbA1c levels based on examinations in the past year, and who have not been advised to visit a hospital
(5) Subjects who have provided voluntary, written informed consent after fully understanding the details of the study
(1) Subjects who may develop allergies to the test food
(2) Subjects with a history of major surgery in the gastrointestinal tract, such as gastrectomy, gastrointestinal suture, or bowel resection
(3) Subjects who have chronic illness or disability in the liver, biliary tract, gastrointestinal tract, circulatory system, kidney, urinary system, psychiatric, nervous and hematological system
(4) Subjects who use health foods that contain ingredients that may affect the blood glucose level (unless they can discontinue use at least 1 week prior to the screening examination)
(5) Subjects who are routinely taking medicines known to affect blood glucose levels
(6) Subjects who are currently taking steroids, protease inhibitors or antipsychotics
(7) Subjects who are participating in another clinical trial at the time of screening
(8) Subjects who are pregnant, breast-feeding, or planning to become pregnant or breast-feeding during the study period
(9) Subjects who are unable to comply with the study requirements
(10) Subjects who are judged as ineligible for the subject of this study by investigator
28
| 1st name | Takato |
| Middle name | |
| Last name | Nikaido |
Yamada Bee Company, Inc.
Functional research section, Institute for Bee Products & Health Science, R&D department
708-0393
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, Japan
0868-54-1199
tn2381@yamada-bee.com
| 1st name | Yukie |
| Middle name | |
| Last name | Nakagawa |
Yamada Bee Company, Inc.
Functional research section, Institute for Bee Products & Health Science, R&D department
708-0393
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, Japan
0868-54-1199
yn2180@yamada-bee.com
Yamada Bee Company, Inc.
Yamada Bee Company, Inc.
Profit organization
Yamada Bee Company Ethics Committee
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, Japan
0868-54-1199
irb@yamada-bee.com
NO
| 2026 | Year | 02 | Month | 20 | Day |
Unpublished
Preinitiation
| 2025 | Year | 10 | Month | 21 | Day |
| 2025 | Year | 11 | Month | 18 | Day |
| 2026 | Year | 02 | Month | 20 | Day |
| 2025 | Year | 11 | Month | 13 | Day |
| 2025 | Year | 11 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068231